FDA Approves New First-in-Class ADHD Drug: What Every American With ADHD Needs to Know
The FDA approved a new first-in-class ADHD medication on July 29, 2026 — the first genuinely novel ADHD mechanism in years. A 40-year pharmacist explains who benefits most, what makes this drug different, and the complete non-medication strategies that amplify ADHD treatment for America’s 8-10 million adults with this condition.